Skip to main content
iCoreConnect Inc. (ICCT)
NASDAQ: ICCT · IEX Real-Time Price · USD
1.095
+0.005 (0.46%)
At close: Apr 26, 2024, 4:00 PM
1.110
+0.015 (1.37%)
After-hours: Apr 26, 2024, 7:52 PM EDT

iCoreConnect Revenue

In the year 2023, iCoreConnect had annual revenue of $8.15M with 2.05% growth. Revenue in the quarter ending December 31, 2023 was $2.45M with 19.87% year-over-year growth.

Revenue (ttm)
$8.15M
Revenue Growth
+2.05%
P/S Ratio
1.36
Revenue / Employee
$121,665
Employees
67
Market Cap
11.12M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20238.15M163.69K2.05%
Dec 31, 20227.99M3.03M61.16%
Dec 31, 20214.96M2.83M133.40%
Dec 31, 20202.12M1.11M109.43%
Dec 31, 20191.01M-75.00K-6.89%
Dec 31, 20181.09M436.00K66.77%
Jun 30, 2017653.00K--
Jun 30, 2016---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cosmos Health 49.59M
Biomerica 5.41M
Elevai Labs 1.71M
Can-Fite BioPharma 743.00K
Inhibikase Therapeutics 260.50K
Organovo Holdings 242.00K
Nexalin Technology 110.75K
China SXT Pharmaceuticals 29.92K
Revenue Rankings

ICCT News

More News